37 patients were included, 25 accepted and 12 refused PEG placement. Among patients who accepted PEG they were: mostly men (p<0.05), of younger age (p<0.05), shorter TOD (p<0.05) better functional status and slower RP (p<0.05), but >BMI loss (NS). Logistic regression between survival groups demonstrated that >RB1 increased risk of short survival [OR 0.003, 95%CI 0.00-0.81, p<0.05], with no influence of NIV, RP and PEG. By KM, PEG placement (yes/no) also did not modify survival; whereas RB1 (≤ or >0.36 points/month) modified survival curves (Log-rank p=0.02).